ARTISTRY-7: A trial looking at the combination of the drugs Nemvaleukin and Pembrolizumab to treat platinum resistant ovarian cancer
This trial is for those with a diagnosis of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer that has become resistant to platinum-based therapy. It is an open label study, which means that both you and your doctor will know what treatment you are receiving.The researchers conducting the trial are testing a new treatment ca…